Evaluation backs safety of 4-in-1 vaccine

Combination vaccines do not overwhelm a child's immune system, assures an expert in pediatric infectious diseases.

Vaccine

A study has found the the MMRV vaccine isn't a danger to very young children. (AAP)

A comprehensive evaluation of the four-in-one combination vaccine given to Australian toddlers - designed to protect against measles, mumps, rubella and chickenpox - has backed its safety.

Known as the MMRV vaccine, it was one of two new combination vaccines added to the immunisation schedule in 2013, reducing the number of injections babies needed.

The change meant that a second dose of the measles-containing vaccine (MCV) was given to children at 18 months as opposed to four years.

"We know that children need two doses," said Dr Kristine Macartney at the Children's Hospital at Westmead.

However there were concerns, raised out of the US, that the MMRV vaccine given to very young children was linked to a greater risk of fever and febrile seizures.

A University of Sydney study, published in journal JAMA Pediatrics, evaluated the way the vaccine is used in Australia.

It found no increase in febrile seizures associated with this second dose given at 18 months.

Researchers at the University of Sydney examined all children who presented to pediatric hospitals across the country with a febrile convulsion, then looked at what vaccines they had received.

"Children were at no particular risk of having seizures after having the vaccine," Dr Maccartney told AAP.

The expert in pediatric infectious diseases says the findings should ease parent concerns that the vaccine does not overwhelm the child's immune system.

Measles is one of the most infectious diseases and the MMRV vaccine now means children have well above 95 per cent protection by the age of two.

"For every case of measles if you had an un-immunised population you would see about 15 more cases just from that one case, so highly contagious," said Dr Macartney.

"Although we have eliminated the virus from this country in terms of what we call endemic continuous circulation, we are constantly getting importations of people with measles, so we need vaccine coverage for measles as close to 100 per cent as we can possibly get so that its blocked from spreading in the community," she said.


Share
2 min read

Published

Source: AAP


Share this with family and friends


Get SBS News daily and direct to your Inbox

Sign up now for the latest news from Australia and around the world direct to your inbox.

By subscribing, you agree to SBS’s terms of service and privacy policy including receiving email updates from SBS.

Download our apps
SBS News
SBS Audio
SBS On Demand

Listen to our podcasts
An overview of the day's top stories from SBS News
Interviews and feature reports from SBS News
Your daily ten minute finance and business news wrap with SBS Finance Editor Ricardo Gonçalves.
A daily five minute news wrap for English learners and people with disability
Get the latest with our News podcasts on your favourite podcast apps.

Watch on SBS
SBS World News

SBS World News

Take a global view with Australia's most comprehensive world news service
Watch the latest news videos from Australia and across the world
Evaluation backs safety of 4-in-1 vaccine | SBS News